These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 8912533

  • 1. Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance.
    Stein U, Walther W, Shoemaker RH.
    Br J Cancer; 1996 Nov; 74(9):1384-91. PubMed ID: 8912533
    [Abstract] [Full Text] [Related]

  • 2. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U, Walther W, Shoemaker RH.
    J Natl Cancer Inst; 1996 Oct 02; 88(19):1383-92. PubMed ID: 8827016
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL, Overman MJ, Petrofski JA, Campbell PA, de Marzo AM, Nelson WG.
    Int J Oncol; 2000 Dec 02; 17(6):1077-86. PubMed ID: 11078791
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs.
    Walther W, Stein U.
    J Cancer Res Clin Oncol; 1994 Dec 02; 120(8):471-8. PubMed ID: 8207045
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
    Stein U, Walther W, Laurencot CM, Scheffer GL, Scheper RJ, Shoemaker RH.
    J Natl Cancer Inst; 1997 Jun 04; 89(11):807-13. PubMed ID: 9182980
    [Abstract] [Full Text] [Related]

  • 9. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L, Durán GE, Chen KG, Dumontet C, Sikic BI.
    J Natl Cancer Inst; 1995 Nov 01; 87(21):1593-602. PubMed ID: 7563202
    [Abstract] [Full Text] [Related]

  • 10. Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules.
    Dassow H, Lassner D, Remke H, Preiss R.
    Int J Clin Pharmacol Ther; 2000 Apr 01; 38(4):209-16. PubMed ID: 10783831
    [Abstract] [Full Text] [Related]

  • 11. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L, Rieger J, Winter S, Streffer J, Esser P, Dichgans J, Meyermann R, Weller M.
    Acta Neuropathol; 2000 May 01; 99(5):555-62. PubMed ID: 10805101
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance.
    Tijerina M, Fowers KD, Kopecková P, Kopecek J.
    Biomaterials; 2000 Nov 01; 21(21):2203-10. PubMed ID: 10985494
    [Abstract] [Full Text] [Related]

  • 14. Multidrug-resistant gene expression in small-cell lung cancer.
    Savaraj N, Wu CJ, Xu R, Lampidis T, Lai S, Donnelly E, Solomon J, Feun LG.
    Am J Clin Oncol; 1997 Aug 01; 20(4):398-403. PubMed ID: 9256898
    [Abstract] [Full Text] [Related]

  • 15. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
    Fogler WE, Pearson JW, Volker K, Ariyoshi K, Watabe H, Riggs CW, Wiltrout RH, Longo DL.
    J Natl Cancer Inst; 1995 Jan 18; 87(2):94-104. PubMed ID: 7707396
    [Abstract] [Full Text] [Related]

  • 16. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW, Zaman GJ, de Haas M, Versantvoort CH, Flens MJ, Scheper RJ, Kamst E, Borst P, Baas F.
    Br J Cancer; 1995 Aug 18; 72(2):298-306. PubMed ID: 7640209
    [Abstract] [Full Text] [Related]

  • 17. Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line.
    Mealey KL, Barhoumi R, Rogers K, Kochevar DT.
    Cancer Lett; 1998 Apr 24; 126(2):187-92. PubMed ID: 9585065
    [Abstract] [Full Text] [Related]

  • 18. Evidence for reversal of multidrug resistance by quinine in LR73 cells without alteration of nuclear pirarubicin uptake and down-regulation of mdr1 gene expression.
    Belhoussine R, Morjani H, Lahlil R, Manfait M.
    Int J Cancer; 1997 Nov 14; 73(4):600-6. PubMed ID: 9389578
    [Abstract] [Full Text] [Related]

  • 19. Use of the human MDR1 promoter for heat-inducible expression of therapeutic genes.
    Walther W, Stein U, Schlag PM.
    Int J Cancer; 2002 Mar 10; 98(2):291-6. PubMed ID: 11857422
    [Abstract] [Full Text] [Related]

  • 20. Co-amplification and over-expression of two mdr genes in a multidrug-resistant human colon carcinoma cell line.
    Chao CC, Ma CM, Lin-Chao S.
    FEBS Lett; 1991 Oct 21; 291(2):214-8. PubMed ID: 1682162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.